Triglav Skladi D.O.O. bought a new stake in Synopsys, Inc. (NASDAQ:SNPS - Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 3,405 shares of the semiconductor company's stock, valued at approximately $1,653,000.
Other hedge funds have also recently made changes to their positions in the company. Whipplewood Advisors LLC bought a new stake in shares of Synopsys in the fourth quarter valued at $33,000. Pilgrim Partners Asia Pte Ltd bought a new stake in shares of Synopsys in the fourth quarter valued at $34,000. Sierra Ocean LLC bought a new stake in shares of Synopsys in the fourth quarter valued at $39,000. Hazlett Burt & Watson Inc. raised its stake in shares of Synopsys by 28.6% in the fourth quarter. Hazlett Burt & Watson Inc. now owns 90 shares of the semiconductor company's stock valued at $44,000 after buying an additional 20 shares during the period. Finally, Annis Gardner Whiting Capital Advisors LLC raised its stake in shares of Synopsys by 50.8% in the fourth quarter. Annis Gardner Whiting Capital Advisors LLC now owns 98 shares of the semiconductor company's stock valued at $48,000 after buying an additional 33 shares during the period. 85.47% of the stock is currently owned by institutional investors.
Synopsys Stock Up 0.4%
SNPS stock traded up $2.02 during trading on Thursday, reaching $503.48. The company's stock had a trading volume of 774,882 shares, compared to its average volume of 1,108,028. Synopsys, Inc. has a 1 year low of $365.74 and a 1 year high of $624.80. The company has a market capitalization of $77.85 billion, a P/E ratio of 34.67, a price-to-earnings-growth ratio of 3.23 and a beta of 1.16. The company's fifty day moving average is $448.95 and its 200-day moving average is $489.21.
Wall Street Analysts Forecast Growth
Several brokerages have recently weighed in on SNPS. Morgan Stanley reduced their price target on Synopsys from $625.00 to $590.00 and set an "overweight" rating for the company in a research report on Monday, February 24th. Stifel Nicolaus set a $550.00 price target on Synopsys in a research report on Monday, April 28th. Needham & Company LLC reiterated a "buy" rating and issued a $650.00 price target on shares of Synopsys in a research report on Thursday, February 27th. Wells Fargo & Company reduced their price target on Synopsys from $540.00 to $520.00 and set an "equal weight" rating for the company in a research report on Thursday, February 27th. Finally, Rosenblatt Securities reissued a "buy" rating and set a $660.00 price objective on shares of Synopsys in a research note on Tuesday, February 25th. One equities research analyst has rated the stock with a hold rating and twelve have issued a buy rating to the company's stock. Based on data from MarketBeat.com, Synopsys currently has an average rating of "Moderate Buy" and an average price target of $614.86.
View Our Latest Stock Report on Synopsys
Insider Buying and Selling at Synopsys
In other Synopsys news, CEO Sassine Ghazi sold 11,366 shares of the stock in a transaction dated Monday, March 3rd. The shares were sold at an average price of $463.75, for a total transaction of $5,270,982.50. Following the completion of the transaction, the chief executive officer now owns 70,922 shares of the company's stock, valued at $32,890,077.50. This represents a 13.81% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Geus Aart De sold 15,705 shares of the stock in a transaction dated Thursday, March 6th. The shares were sold at an average price of $444.42, for a total transaction of $6,979,616.10. Following the completion of the transaction, the insider now directly owns 116,671 shares of the company's stock, valued at approximately $51,850,925.82. The trade was a 11.86% decrease in their position. The disclosure for this sale can be found here. Insiders own 0.62% of the company's stock.
Synopsys Profile
(
Free Report)
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
Further Reading

Before you consider Synopsys, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synopsys wasn't on the list.
While Synopsys currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.